Neurodegenerative Diseases Progression Markers (MARKERS-NDD)
Recruiting
Observational Study
Neurodegenerative Diseases
Parkinson Disease
Synucleinopathies
Lewy Body Disease
Multiple System Atrophy
Tauopathies
Alzheimer Disease
Corticobasal Degeneration
Supranuclear Palsy, Progressive
Atypical Parkinsonism
TDP-43 Proteinopathies
Amyotrophic Lateral Sclerosis
Frontotemporal Lobar Degeneration
Movement Disorders
Cognitive Impairment
Dementia
Iron Overload
Neurodegeneration With Brain Iron Accumulation (NBIA)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 10 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 600 (estimated)
- Sponsor
- Casa di Cura San Raffaele Cassino · Research network
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
MARKERS-NDD is a prospective, observational, longitudinal study, which aims to collect data from patients affected by neurodegenerative diseases (NDD) followed longitudinally for routine examinations performed as part of normal clinical practice. Data collected from clinical evaluations, movement analysis, brain imaging, neuropsychological and electroencephalographic assessments, blood chemistry t…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with diagnosis of Parkinson's Disease, Parkinsonism and Movement Disorders
* Patients with diagnosis of Parkinson's Disease
* Diagnosis of Parkinson's Disease according to the United Kingdom (UK) Parkinson's Disease Society Brain Bank
* Diagnosis of Movement…
Contacts